MIPS 462 Bone Density

XMLWordPrintable

    • Type: EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Priority: Moderate
    • Component/s: None
    • None
    • Hide
      ​Thank you for your question on CMS645 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy. The measure uses RXNorm codes found in the Androgen deprivation therapy for Urology Care (2.16.840.1.113762.1.4.1151.48) valueset to define ADT. The codes to valueset can be found on the NIH Value Set Authority Center website: https://vsac.nlm.nih.gov/. The measure logic then uses the ADT medication order or medication active start dates to meet the measure criteria.
      Show
      ​Thank you for your question on CMS645 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy. The measure uses RXNorm codes found in the Androgen deprivation therapy for Urology Care (2.16.840.1.113762.1.4.1151.48) valueset to define ADT. The codes to valueset can be found on the NIH Value Set Authority Center website: https://vsac.nlm.nih.gov/ . The measure logic then uses the ADT medication order or medication active start dates to meet the measure criteria.
    • CMS0645v6
    • High

      Hi,

      I am reaching out to you to gather more information surrounding how we should define ADT (Androgen Deprivation Therapy). The specification does not specifically state how this should be defined. Should we use codes, drug names?

            Assignee:
            Mathematica EC eCQM Team (Inactive)
            Reporter:
            Andrea Howard (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: